Moreover, the peritoneal administration of HNE or the GPX4 inhibitor RSL3, mitigated LPS-induced acute lung injury and sepsis by decreasing IL-1β and IL-18 secretion in vivo [92]. This evidence concerns the gene GPX4 and Sepsis.